IRadimed Corporation
IRMD
$52.21
$0.771.50%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 13.37% | -0.35% | 17.26% | 21.44% | 23.58% |
Total Depreciation and Amortization | -5.11% | 4.05% | 6.24% | 23.82% | 129.64% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -15.84% | 41.96% | -79.56% | 75.84% | -34.41% |
Change in Net Operating Assets | 115.74% | 171.23% | 791.83% | -1,240.41% | -85.34% |
Cash from Operations | 53.02% | 554.53% | 88.93% | -16.42% | 28.75% |
Capital Expenditure | -424.57% | -1,136.61% | -454.40% | 95.77% | -106.08% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -164.22% | -53.93% | 21.99% | -29.24% | 52.74% |
Cash from Investing | -383.04% | -813.78% | -235.66% | 92.70% | -34.15% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -84.47% | -- | -54.79% | -- | -- |
Repurchase of Common Stock | -25.58% | 43.31% | 34.19% | -28.06% | -117.63% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | 39.68% | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -820.60% | -6,009.24% | -2,082.96% | 39.43% | -32.29% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -83.00% | 245.43% | 11.91% | 69.47% | 27.37% |